All stock lists
Unlock the score
AgomAb Therapeutics NV (NASDAQ:AGMB)
Belgium · Delayed Price · Currency is USD
Healthcare · Biotechnology
8.76-0.29 (-3.19%)
Insider Score
/ 100
AGMB Insider Score
AgomAb Therapeutics NV has a live Insider Score.
Scored on 10 qualifying trades from 3 insiders in the last 90 days.
AGMB analyst forecast
No analyst ratings in the last 12 months
No independent sell-side analyst publishes on AGMB that our data provider carries. That is normal for smaller listings, and it is not a judgement on the company. Here is what we track instead:
- Insider activity and the Insider Score — what the people who run the company are doing with their own money.
- Promoter Scores — any disclosed paid stock promotion on this ticker.
Best analysts covering AGMB
No firm covering AGMB has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
AGMB earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-25 | -0.52 | -0.36 | $0 | $0 |
| 2026-04-23 | -0.52 | -45.69 | $0 | $0 |
| 2026-08-06 | 1.18 | -0.91 | $0 | $0 |
| 2027-03-03 | -0.95 | 0.00 | $0 | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.